Cies JJ - Search Results

1

Population pharmacokinetics of piperacillin/tazobactam in critically ill young children.

Cies JJ, Shankar V, Schlichting C, Kuti JL. Cies JJ, et al. Pediatr Infect Dis J. 2014 Feb;33(2):168-73. doi: 10.1097/INF.0b013e3182a743c7. Pediatr Infect Dis J. 2014. PMID: 23907263

2

Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia.

Cies JJ, Jain J, Kuti JL. Cies JJ, et al. Pediatr Blood Cancer. 2015 Mar;62(3):477-82. doi: 10.1002/pbc.25287. Epub 2014 Oct 18. Pediatr Blood Cancer. 2015. PMID: 25328131 Clinical Trial.

3

Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis.

Kuti JL, Pettit RS, Neu N, Cies JJ, Lapin C, Muhlebach MS, Novak KJ, Nguyen ST, Saiman L, Nicolau DP. Kuti JL, et al. Among authors: cies jj. Diagn Microbiol Infect Dis. 2015 Sep;83(1):53-5. doi: 10.1016/j.diagmicrobio.2015.04.012. Epub 2015 May 1. Diagn Microbiol Infect Dis. 2015. PMID: 26003469

4

Population pharmacokinetics of meropenem administered as a prolonged infusion in children with cystic fibrosis.

Pettit RS, Neu N, Cies JJ, Lapin C, Muhlebach MS, Novak KJ, Nguyen ST, Saiman L, Nicolau DP, Kuti JL. Pettit RS, et al. Among authors: cies jj. J Antimicrob Chemother. 2016 Jan;71(1):189-95. doi: 10.1093/jac/dkv289. Epub 2015 Sep 27. J Antimicrob Chemother. 2016. PMID: 26416780

5

Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation.

Monogue ML, Pettit RS, Muhlebach M, Cies JJ, Nicolau DP, Kuti JL. Monogue ML, et al. Among authors: cies jj. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6578-6584. doi: 10.1128/AAC.01566-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27550351 Free PMC article. Clinical Trial.

6

Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation.

Kidd JM, Sakon CM, Oleksiuk LM, Cies JJ, Pettit RS, Nicolau DP, Kuti JL. Kidd JM, et al. Among authors: cies jj. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01914-19. doi: 10.1128/AAC.01914-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31685468 Free PMC article. Clinical Trial.

7

Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.

Cies JJ, Shankar V. Cies JJ, et al. Pharmacotherapy. 2013 Apr;33(4):392-400. doi: 10.1002/phar.1227. Epub 2013 Mar 7. Pharmacotherapy. 2013. PMID: 23471688

8

Meropenem time above the MIC exposure is predictive of response in cystic fibrosis children with acute pulmonary exacerbations.

Kuti JL, Pettit RS, Neu N, Cies JJ, Lapin C, Muhlebach MS, Novak KJ, Nguyen ST, Saiman L, Nicolau DP. Kuti JL, et al. Among authors: cies jj. Diagn Microbiol Infect Dis. 2018 Jul;91(3):294-297. doi: 10.1016/j.diagmicrobio.2018.01.020. Epub 2018 Feb 24. Diagn Microbiol Infect Dis. 2018. PMID: 29661528 Clinical Trial.

9

Procalcitonin use in a pediatric intensive care unit.

Cies JJ, Chopra A. Cies JJ, et al. Pediatr Infect Dis J. 2014 Sep;33(9):984-6. doi: 10.1097/INF.0000000000000370. Pediatr Infect Dis J. 2014. PMID: 24747152

10

Cefoxitin Prophylaxis During Pediatric Cardiac Surgery: Retrospective Exploration of Postoperative Trough Levels.

Ricci Z, Benegni S, Cies JJ, Marinari E, Haiberger R, Garisto C, Cairoli S, Di Chiara L, Goffredo B. Ricci Z, et al. Among authors: cies jj. Pediatr Infect Dis J. 2019 May;38(5):484-489. doi: 10.1097/INF.0000000000002179. Pediatr Infect Dis J. 2019. PMID: 30169486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page